21 Participants Needed

Telehealth Exercise for Post-Transplant Frailty

Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: City of Hope Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This clinical trial studies the feasibility of implementing a telehealth exercise platform to reduce frailty in patients after bone marrow transplant.The exercise program uses a telehealth platform (e.g. smart phones, tablets or computers) to view pre-recorded exercise videos on coordination, posture, stretching, balance and resistance/aerobic training.Physical activity may help to improve physical function, including frailty, after bone marrow transplant. Information from this trial may help researchers design future telehealth exercise routines for treating people with cancer.

Research Team

KL

Kyuwan Lee

Principal Investigator

City of Hope Medical Center

Eligibility Criteria

This trial is for adults over 18 who are at least two years post-bone marrow transplant, in remission, and identified as pre-frail or frail. They must be able to consent, perform study procedures, speak English, and have internet plus a smartphone. Excluded are those with exercise contraindications like acute infections or physical disabilities, regular exercisers (>60 mins/week), those with serious heart conditions, or women who are pregnant/planning pregnancy.

Inclusion Criteria

English speaking
You have a condition called pre-frailty or frailty, identified by a questionnaire called the Bone Marrow Transplant Survivorship Study (BMTSS). This means you may have symptoms like being underweight, feeling exhausted, having low energy, walking slowly, and having weak muscles. If you have at least three out of five of these symptoms, you are considered frail, and if you have two out of five, you are considered pre-frail.
Has access to the internet and a smartphone
See 3 more

Exclusion Criteria

I have a history of serious heart problems.
I am pregnant or planning to become pregnant.
You need to exercise for more than 60 minutes every week.
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants in Arm A participate in telehealth exercise sessions at home over 30 minutes with a trainer 3 days a week for 8 weeks. Arm B participants maintain normal activities for 8 weeks before starting the exercise program.

8 weeks
24 sessions (virtual)

Follow-up

Participants are monitored for changes in physical functioning, including chair stand, gait speed, and timed balance.

1 week

Treatment Details

Interventions

  • Exercise Intervention
Trial Overview The trial tests a telehealth exercise program aimed at reducing frailty after bone marrow transplant. Participants will use devices like smartphones to follow online videos covering exercises such as coordination and balance training. The goal is to improve physical function and design future telehealth routines for cancer patients.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Arm A (telehealth intervention)Experimental Treatment3 Interventions
Patients participate in telehealth exercise sessions at home over 30 minutes with a trainer 3 days a week for 8 weeks (24 total sessions).
Group II: Arm B (delayed exercise intervention)Active Control3 Interventions
Patients maintain their normal activities of daily living for 8 weeks before participating in the telehealth exercise program as described in Arm I.

Find a Clinic Near You

Who Is Running the Clinical Trial?

City of Hope Medical Center

Lead Sponsor

Trials
614
Recruited
1,924,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security